Company Overview of Takeda Italia S.p.A.
Takeda Italia S.p.A. develops and manufactures medicines and drugs for the treatment of peptic ulcers, prostate cancer and endometriosis, urological diseases, diabetes and hypertension, respiratory and inflammatory diseases, osteoporosis, and pain management. It was formerly known as Nycomed S.p.A. and changed its name to Takeda Italia S.p.A. in January 2013. The company was founded in 1982 and is based in Rome, Italy. Takeda Italia S.p.A. operates as a subsidiary of Takeda Pharmaceutical Company Limited.
Via Elio Vittorini, 129
Rome, RM 00144
Founded in 1982
39 06 502601
39 065 011709
Key Executives for Takeda Italia S.p.A.
Takeda Italia S.p.A. does not have any Key Executives recorded.
Similar Private Companies By Industry
|A. Menarini Industrie Farmaceutiche Riunite Srl||Europe|
|Aboca S.p.A. - Societa Agricola||Europe|
|ACS Dobfar S.p.A.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Takeda Italia S.p.A., please visit www.takeda.it. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.